4
Changes in Ownership
Evolent Health, Inc. Filed Acc 0000950157-16-002176
Chief Financial Officer sold 21,205 shares at $21.54 ($456,756)
- Chief Financial Officer acquired 21,205 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
McGrane Nicholas · Chief Financial Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-09-14 | Exercise or conversion : show line 1 in the form | +21,205 | $3.84 | $81,427 | 136,495 | D |
| 2016-09-14 | Sale : show line 2 in the form | −21,205 | $21.54 | $456,756 | 115,290 | D |
| Open-market sales · 21,205 sh · avg $21.54 · $456,756 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2016-09-14 | Exercise or conversion : show line 3 in the form Class A Common Stock Option (right to buy) | −21,205 | $3.84 | 2024-10-22 | 21,205 | 278,795 | D |
Loading xslF345X03/form4.xml…